CONCORD, Calif.--(BUSINESS WIRE)--Jul. 15, 2009--
Cerus Corporation (NASDAQ:CERS) announced today that its second quarter
2009 financial results will be released on Thursday, July 30, 2009,
after the close of the market. The company will host a conference call
and webcast at 4:30 p.m. EDT that afternoon, during which management
will discuss the company's financial results and provide a general
business overview.
To access the live webcast, please visit the Investor Relations page of
the Cerus web site at http://cerus2013.q4web.com.
Alternatively, you may access the live conference call by dialing
877-407-0782 (U.S.) or 201-689-8567 (international).
A replay will be available on the Cerus web site, or by dialing
877-660-6853 (U.S.) or 201-612-7415 (international) and entering account
number 286 and conference ID number 300291. The replay will be available
approximately two hours after the call through August 7, 2009.
ABOUT CERUS
Cerus Corporation is a biomedical products company focused on
commercializing the INTERCEPT Blood System to enhance blood safety. The
INTERCEPT Blood System is designed to inactivate blood-borne pathogens
in donated blood components intended for transfusion. Cerus currently
markets the INTERCEPT Blood System for both platelets and plasma in
Europe, Russia, the Middle East and selected countries in other regions
around the world. The INTERCEPT red blood cell system is currently in
clinical development. See http://www.cerus.com
for more information.
INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus
Corporation.
Source: Cerus Corporation
Cerus Corporation
Kevin D. Green, 925-288-6138
Vice President,
Finance & CAO